DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Prospective Data Collection on Cementless Oxford Partial Knee

Information source: Biomet, Inc.
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Arthroplasty, Replacement, Knee

Intervention: Cementless Oxford Partial Knee (Device)

Phase: N/A

Status: Recruiting

Sponsored by: Biomet, Inc.

Summary

Prospective data collection on clinical and radiographic outcomes of Cementless oxford Partial Knee.

Clinical Details

Official title: Prospective Clinical Evaluation of the Cementless Oxford Partial Knee

Study design: Cohort, Prospective

Primary outcome: American Knee Society Score

Secondary outcome:

Radiographic Assessment

Oxford Knee Score, SF12

Detailed description: Prospective radiographic and clinical data collection on outcomes of Cementless oxford Partial Knee. Screened radiographs are taken postoperatively and after 12 months. Oxford Knee Scores, SF12 Health Questionnaires and American Knee Society Radiographic Assessment are taken at 12 month follow-up.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

1. Patients undergoing primary knee arthroplasty

2. Patients with one of the following primary diagnoses in the medial compartment of the knee:

- Osteoarthritis,

- Avascular necrosis

Exclusion criteria:

1. Inability to co-operate with and complete the study.

2. Inadequate fixation of cementless components. If either before or after randomization the surgeon feels that cementless fixation is inadequate, cemented components should be inserted.

Locations and Contacts

Rami Sorial , FRACS, Penrith, Australia; Recruiting
R Sorial, FRACS, Phone: 02.4721.2217
Additional Information

Starting date: July 2004
Ending date: September 2012
Last updated: October 2, 2008

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009